Virtu Financial’s Moderna MRNA Stock Holding History

Virtu Financial’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-82,217	Closed	-$2.42M	–	2044
2025 Q4	$2.42M	Buy	+82,217	New	+$2.23M	0.09%	122
2024 Q3	–	Sell	-73,663	Closed	-$8.75M	–	1692
2024 Q2	$8.75M	Buy	+73,663	New	+$9.32M	0.61%	15
2023 Q4	–	Sell	-25,294	Closed	-$2.61M	–	1850
2023 Q3	$2.61M	Buy	+25,294	New	+$2.82M	0.26%	63
2023 Q1	–	Sell	-30,393	Closed	-$5.46M	–	1866
2022 Q4	$5.46M	Buy	+30,393	New	+$4.97M	0.72%	7
2022 Q1	–	Sell	-6,531	Closed	-$1.66M	–	1821
2021 Q4	$1.66M	Buy	+6,531	New	+$1.91M	0.17%	122
2021 Q2	–	Sell	-17,361	Closed	-$2.27M	–	1861
2021 Q1	$2.27M	Buy	+17,361	New	+$2.52M	0.16%	90
2020 Q4	–	Sell	-4,297	Closed	-$304K	–	1661
2020 Q3	$304K	Buy	+4,297	New	+$300K	0.05%	431
2019 Q3	–	Sell	-11,270	Closed	-$165K	–	1681
2019 Q2	$165K	Buy	+11,270	New	+$242K	0.01%	1060

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's MRNA Position: Q1 2026 in Review

Virtu Financial sold out of Moderna (MRNA) in Q1 2026, closing a stake of 82,217 shares — an estimated $2.42M sold.

Virtu Financial first reported a position in MRNA in Q2 2019 and held it in 8 quarters. The position peaked at $8.75M in Q2 2024. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Virtu Financial reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 82,217 Moderna shares in Q1 2026, an estimated $2.42M.
Virtu Financial first reported a position in Moderna in Q2 2019 and held it in 8 quarters.
Virtu Financial's Moderna position peaked at $8.75M in Q2 2024.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.